INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 August 2012
Total net assets |
£128.9m |
NAV per share |
232.0p |
Share price |
204.5p |
Total value of unquoted investments |
£20.6m |
Total number of portfolio companies |
70 |
Cash |
7% NAV |
Cash committed and reserved to unquoted investments |
(6)% NAV |
Portfolio companies with < 1 year of cash |
15.81% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen Celgene Alexion |
6.8 5.4 5.0 |
Aptiv |
3.6 |
Insulet |
3.0 |
Pharmaxis |
2.9 |
Gilead |
2.9 |
Onyx |
2.5 |
Teva Vertex |
2.3 2.3 |
|
----------- |
Total |
36.7 |
Geographical Allocation |
% |
United States & Canada |
79 |
Europe |
8 |
Australia Israel |
3 3 |
Cash |
7 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
77 |
Unquoted |
16 |
Cash |
7 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 SEPTEMBER 2012